← Leaderboards
Emily M Jutkiewicz
University Of Michigan At Ann Arbor
$3,827,799
Attributed
$5,615,578
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,615,578 · 3
By mechanism
R01$5,188,453 · 2
R21$427,125 · 1
Top collaborators
- Alan V. Smrcka7 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Henry Isaac Mosberg$11,490,941
- John R Traynor$25,558,598
- James H Woods$18,938,311
- David L Roman$2,842,817
- Natalia Harris$136,935
Others in their field
Other Emerging Leaders on “Property”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Hobbs · Suny At Stony Brook$42,194,917
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,689,447
- Eric C Palm · Florida State University$35,115,872
Research focus
PropertyPharmaceutical PreparationsChronicRewardsAddictionOpioidMediatingAmericanBrainReportingReceptor SignalingPathway InteractionsLeadBindingIn VivoPharmacologyBaseConstipationAnalgesicsChronic PainPhysical DependenceChronic Inflammatory PainPainOpioid Analgesics
Grant awards (14)
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$658,309
R01 · FY2023 · DA
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$675,475
R01 · FY2022 · DA
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$692,132
R01 · FY2021 · DA
Endogenous enkephalins and reward mechanisms$306,740
R01 · FY2021 · DA · contact PI
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$71,114
R01 · FY2021 · DA
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$708,318
R01 · FY2020 · DA
Endogenous enkephalins and reward mechanisms$313,482
R01 · FY2020 · DA · contact PI
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$71,114
R01 · FY2020 · DA
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics$699,097
R01 · FY2019 · DA
Endogenous enkephalins and reward mechanisms$320,224
R01 · FY2019 · DA · contact PI
Endogenous enkephalins and reward mechanisms$326,966
R01 · FY2018 · DA · contact PI
Abuse potential of a novel bifunctional opioid ligand$233,375
R21 · FY2018 · DA · contact PI
Endogenous enkephalins and reward mechanisms$345,482
R01 · FY2017 · DA · contact PI
Abuse potential of a novel bifunctional opioid ligand$193,750
R21 · FY2017 · DA · contact PI